Physiological and Neurocognitive Responses to Multisensory Food Cues in VR
Investigation of Physiological and Neurocognitive Responses to Multisensory Food Cues in an Virtual Reality Environment
1 other identifier
interventional
34
1 country
1
Brief Summary
This study aims to investigate how food cravings change when visual food cues are enriched with sound, smell, and interactive experiences in a virtual reality (VR) environment. A total of 34 healthy Marmara University students aged 18 and older will participate in the study between November 2025 and March 2026, with a possible extension until September 2026. Participants will be exposed to real, virtual, and multisensory food cues, and their food craving levels, saliva composition, blood glucose, EEG activity, and body temperature will be measured. Salivary alpha-amylase will be analysed as a biomarker of physiological arousal during food cue exposure. The study aims to compare how virtual food cues affect food craving and physiological responses compared to real food cues. Findings are expected to contribute to understanding eating behaviour, developing VR-based interventions for healthy nutrition, and encouraging interdisciplinary collaboration between nutrition and engineering fields.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2025
CompletedFirst Posted
Study publicly available on registry
January 6, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
April 28, 2026
April 1, 2026
5 months
December 3, 2025
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in EEG activation patterns in response to food cues
Change in neural activation patterns measured by electroencephalography (EEG) in response to food cues presented in real-world and virtual reality environments. EEG data will be recorded using a 16-channel Brain Products LiveAmp system, assessing event-related potentials (P300, N200) and frequency band power (delta, theta, alpha, beta) across reward- and attention-related cortical regions.
Baseline and peri-procedural (during exposure to food cues) within a single study session.
Food craving questionnaire score
Assesses subjective food craving responses using the Food Cravings Questionnaire-State (FCQ-S). Total scores range from 15 to 75, with higher scores indicating greater momentary food craving intensity.
Baseline and immediately after completion of all experimental cue conditions within a single study session.
Salivary α-amylase concentration (µU/mL)
Salivary alpha-amylase concentration will be measured as an objective indicator of autonomic nervous system activation and physiological arousal in response to food cues presented in real-world and virtual reality environments.
Baseline and peri-procedural (during exposure to food cues) within a single study session.
Secondary Outcomes (5)
Salivary flow rate (mL/min)
Baseline and peri-procedural (during exposure to food cues) within a single study session.
Capillary blood glucose level (mg/dL)
Measured pre-exposure and immediately post-exposure for each condition.
Subjective appetite rating score
Baseline and immediately after completion of each experimental cue condition within a single study session.
Body surface temperature (°C)
Baseline, during experimental cue exposure, and immediately post-exposure within a single study session.
Presence questionnaire score
Immediately after completion of all virtual reality experimental conditions within a single study session.
Study Arms (1)
Healthy Volunteer Participants
EXPERIMENTALParticipants will be exposed to real, virtual, and multisensory food cues, and their food craving levels, saliva composition, blood glucose, EEG activity, and body temperature will be measured. Salivary alpha-amylase will be analysed as a biomarker of physiological arousal during food cue exposure. University students aged 18 and older will participate in the study.
Interventions
Participants will be exposed to real foods and their food craving levels, saliva composition, blood glucose, EEG activity, and body temperature will be measured. Salivary alpha-amylase will be analysed as a biomarker of physiological arousal during food cue exposure.
Participants will be exposed to vitrual foods and their food craving levels, saliva composition, blood glucose, EEG activity, and body temperature will be measured. Salivary alpha-amylase will be analyse
Eligibility Criteria
You may qualify if:
- Being over 18 years of age.
- Individuals with a normal Body Mass Index according to the WHO classification.
- No known food allergies or eating disorder diagnoses.
- Voluntarily agree to participate in the study and sign an informed consent form.
- Be physically and psychologically suitable for virtual reality environment and electroencephalography (EEG) recording applications.
You may not qualify if:
- History of any neurological disease (e.g., epilepsy, vertigo) that may prevent the use of virtual reality goggles
- Allergy, intolerance, or sensitivity to foods used in the experimental procedure (e.g., chocolate biscuits, pickles)
- Significant loss or impairment of vision, hearing, or sense of smell.
- Sensitivity to the use of virtual reality devices (e.g. history of cyber sickness such as nausea, dizziness, etc.)
- Use of psychiatric medication, antidepressants, neuroleptics, or medication that may affect neurological status
- History of psychological conditions that may affect the working process, such as attention deficit, anxiety disorder, or panic attacks.
- Any discomfort in the salivary glands, insufficient saliva production, or dry mouth.
- Consumption of more than 21 units of alcohol per week (as this may affect food cravings and physiological parameters).
- History or diagnosis of abnormal brain electrical activity that may affect EEG measurements.
- History of substance dependence or any mental disorder that may affect cortical activity.
- Conditions that prevent body composition analysis (BIA) measurements (e.g. use of a pacemaker, limb amputation, lymphoedema, etc.).
- The presence of any language or cognitive barrier that prevents communication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University, Faculty of Health Sciences
Istanbul, Maltepe, 34854, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
December 3, 2025
First Posted
January 6, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
August 25, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
April 28, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) collected in this study will not be shared publicly. The data include sensitive physiological and neurocognitive measurements (EEG and salivary biomarkers) collected as part of a graduate thesis project. Data will be used solely for the purposes of the primary analyses described in the protocol and related scientific publications.